AOD-9604 and HGH Fragment 176-191 Interaction

Avoid
Researched 95% confidence

AOD-9604 and HGH Fragment 176-191 have a potentially harmful interaction with 95% confidence. Same mechanism of action. AOD-9604 is a modified version of this fragment; using both is redundant and unnecessary. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

AOD-9604

Modified hGH Fragment | Fat Loss Peptide

Stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor upregulation, without binding to the GH receptor. Does not affect glucose metabolism or increase IGF-1 levels.

Half-life: 3-4 minutes Typical dose: 250-500mcg weight loss, metabolic
teratogenic
View full profile

HGH Fragment 176-191

Growth Hormone Fragment | Fat Loss Peptide

Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.

Half-life: 15-20 minutes Typical dose: 250-500mcg weight loss, metabolic
carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (AOD-9604, HGH Fragment 176-191). Monitor accordingly.

Frequently Asked Questions

Can I take AOD-9604 with HGH Fragment 176-191?

Combining AOD-9604 with HGH Fragment 176-191 is not recommended. Same mechanism of action. AOD-9604 is a modified version of this fragment; using both is redundant and unnecessary.

Is AOD-9604 and HGH Fragment 176-191 safe together?

This combination carries significant risk. Same mechanism of action. AOD-9604 is a modified version of this fragment; using both is redundant and unnecessary. Consult a healthcare professional before combining.

What are the interactions between AOD-9604 and HGH Fragment 176-191?

Same mechanism of action. AOD-9604 is a modified version of this fragment; using both is redundant and unnecessary. This assessment has 95% confidence and is based on documented research data.

How should I time AOD-9604 and HGH Fragment 176-191?

AOD-9604 has a half-life of 3-4 minutes and HGH Fragment 176-191 has a half-life of 15-20 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: AOD-9604 vs HGH Fragment 176-191

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.